| pubmed-article:16538517 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16538517 | lifeskim:mentions | umls-concept:C1332166 | lld:lifeskim |
| pubmed-article:16538517 | lifeskim:mentions | umls-concept:C0031715 | lld:lifeskim |
| pubmed-article:16538517 | lifeskim:mentions | umls-concept:C0036720 | lld:lifeskim |
| pubmed-article:16538517 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
| pubmed-article:16538517 | lifeskim:mentions | umls-concept:C0596611 | lld:lifeskim |
| pubmed-article:16538517 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:16538517 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:16538517 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:16538517 | pubmed:dateCreated | 2006-5-16 | lld:pubmed |
| pubmed-article:16538517 | pubmed:abstractText | As inactivation of p53 may be correlated with poor response of tumors to chemo- and/or radiotherapy the presence of p53 mutations in exons 5-8 was determined in adenocarcinomas of the gastroesophageal junction (GEJ). As p53 protein phosphorylation at serine 15 indicates stabilization and protection against mdm-2 the presence of this phosphorylation state was subsequently evaluated. | lld:pubmed |
| pubmed-article:16538517 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16538517 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16538517 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16538517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16538517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16538517 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16538517 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:16538517 | pubmed:issn | 0171-5216 | lld:pubmed |
| pubmed-article:16538517 | pubmed:author | pubmed-author:SarbiaMarioM | lld:pubmed |
| pubmed-article:16538517 | pubmed:author | pubmed-author:KellerGiselaG | lld:pubmed |
| pubmed-article:16538517 | pubmed:author | pubmed-author:StahlMichaelM | lld:pubmed |
| pubmed-article:16538517 | pubmed:author | pubmed-author:Pühringer-Opp... | lld:pubmed |
| pubmed-article:16538517 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16538517 | pubmed:volume | 132 | lld:pubmed |
| pubmed-article:16538517 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16538517 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16538517 | pubmed:pagination | 433-8 | lld:pubmed |
| pubmed-article:16538517 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:meshHeading | pubmed-meshheading:16538517... | lld:pubmed |
| pubmed-article:16538517 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16538517 | pubmed:articleTitle | Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction. | lld:pubmed |
| pubmed-article:16538517 | pubmed:affiliation | Institute of Pathology, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany. | lld:pubmed |
| pubmed-article:16538517 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16538517 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16538517 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16538517 | lld:pubmed |
